BioVie Inc.
BIVI
$0.8408
$0.04766.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 15.34% | 61.23% | 45.78% | 46.36% | 46.44% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -92.18% | -74.87% | -61.27% | -44.60% | 108.58% |
| Total Other Non-Cash Items | 128.49% | -18.24% | 288.29% | -32.37% | -95.85% |
| Change in Net Operating Assets | -206.50% | 96.86% | 37.73% | -34.65% | 257.62% |
| Cash from Operations | -45.26% | 70.60% | 64.51% | 50.14% | 26.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | 100.00% | -- |
| Cash from Investing | -- | -- | 100.00% | 100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -34.00% | 0.00% | -- | -- | -- |
| Issuance of Common Stock | 119.85% | 18.54% | -100.00% | 89.13% | -77.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 163.45% | 59.46% | -297.10% | 63.54% | -84.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 543.53% | -317.84% | 44.93% | 169.95% | -104.03% |